EDGAR Filing Documents for 0000909661-06-000061

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000909661-06-000061

Filing Date

2006-12-07

Accepted

2006-12-07 17:05:51

Documents

Group Members

CHUN R. DINGDAVID I. COHENDEREK C. SCHRIERFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFFSHORE INVESTORS II, L.P.FARALLON CAPITAL PARTNERS,

Document Format Files

Seq	Description	Document	Type	Size
1		crl13g.txt	SC 13G	100912
	Complete submission text file	0000909661-06-000061.txt		104426

Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132

FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13G

Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887

Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000

CHARLES RIVER LABORATORIES INTERNATIONAL INC (Subject) CIK: 0001100682 (see all company filings)

IRS No.: 061397316
Type: SC 13G | Act: 34 | File No.: 005-59553 | Film No.: 061263319
SIC: 2836 Biological Products, (No Diagnostic Substances)